Linagliptin-metformin oral tablet is available as a brand-name drug. It’s not available as a generic drug. Brand name: Jentadueto. Linagliptin-metformin comes as an immediate-release oral tablet and ...
San Diego, CA - Linagliptin (Tradjenta, Boehringer Ingelheim) shows similar efficacy to glimepiride (Amaryl, Sanofi-Aventis) for the treatment of patients with type 2 diabetes, in terms of controlling ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Sulfonylureas are often added to metformin to improve glycemic control, but at the known risk of increasing hypoglycemia and weight gain. In a report published in the Lancet, more than 1,500 patients ...
Linagliptin is the only diabetes treatment to be approved once daily, one dosage strength for all adult patients without any need for dose adjustments Ingelheim, Germany 25.08.2011- Boehringer ...
Review the side-effects of Linagliptin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Amit Bansal, Managing Director, Theon Pharmaceuticals Ltd says this fixed-dose combination tablet of linagliptin, dapagliflozin, and metformin hydrochloride is a suitable option for the following ...
Heart Failure Linked to Loss of Cerebral Gray Matter The dipeptidyl peptidase-4 inhibitor linagliptin is noninferior to the sulphonylurea glimepiride for second-line glycemic control and is associated ...
Diabetes mellitus is a significant and growing health problem which contributes significantly to the prevalence of chronic kidney disease (CKD). According to the ERA-EDTA Registry, nearly a quarter ...
Boehringer Ingelheim (BI) has released a fistful of data from Phase III clinical trials showing that the DPP-4 inhibitor linagliptin, the most advanced compound in the company’s diabetes portfolio, ...
Senior patient in hospital explaining pain to doctor or nurse Linagliptin is safe for patients with type 2 diabetes and cardiorenal disease. SAN FRANCISCO — Linagliptin is safe for patients with type ...
Boehringer Ingelheim and Eli Lilly and Company's DPP-4 inhibitor today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee RIDGEFIELD, Conn. and INDIANAPOLIS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results